Valuation: Cellnovo

Market Cap 2.44M 2.16M 2.02M 1.83M 3.46M 235M 3.49M 24.3M 9.45M 120M 9.14M 8.95M 385M P/E 2018 *
-0.15x
P/E 2019 * -
Enterprise Value 12.46M 11.06M 10.35M 9.38M 17.72M 1.2B 17.84M 124M 48.34M 613M 46.76M 45.76M 1.97B EV / Sales 2018
8.63x
EV / Sales 2019 * -
Free-Float
99.67%
Yield 2018 *
-
Yield 2019 * -
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 2.68M
+0.78%+4.00%+0.14%+61.74% 3,900B
+1.41%+2.73%+6.98%+1,056.35% 455B
+1.61%+5.07%-50.35%+31.66% 432B
+3.23%+8.11%+97.53%+240.44% 333B
+2.27%+6.14%+124.91%+531.30% 280B
+1.92%+2.49%-18.05%+54.41% 239B
+1.39%+6.18%-24.43%+23.03% 141B
+3.88%+8.70%+121.43%+219.16% 135B
+0.66%+3.60%+76.82%+194.65% 99.25B
Average +1.43%+4.10%+37.22%+268.08% 601.38B
Weighted average by Cap. +1.52%+4.26%+10.91%+171.12%

Financials

2018 2019 *
Net sales 3.32M 2.95M 2.76M 2.5M 4.72M 320M 4.76M 33.14M 12.89M 163M 12.47M 12.2M 525M -
Net income -15.94M -14.15M -13.24M -12M -22.67M -1.54B -22.83M -159M -61.85M -784M -59.83M -58.55M -2.52B -
Net Debt 10.02M 8.9M 8.33M 7.55M 14.25M 966M 14.35M 99.99M 38.89M 493M 37.62M 36.81M 1.58B -
Logo Cellnovo
Cellnovo Group SA is a France-based company principally engaged in medical instrument manufacturing . The Company specialized in the development of a mobile system for managing type 1 diabetes. Its apparatus includes a cordless micro-pump (a patch pump), an integrated monitoring device and a cellular handset with touch screen with an embedded blood glucose meter. The Company system enables diabetics to live a normal life whilst closely monitoring their glycaemia, their use of insulin, their activity and their food intake.
Employees
-
  1. Stock Market
  2. Stocks
  3. CLNV Stock